Goldman Sachs analyst Nathan Rich maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and lowers the price target from $578 to $500.
Goldman Sachs Maintains Buy on IDEXX Laboratories, Lowers Price Target to $500
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.